Politiparty
Politiparty

118th Congress Health

H.R. 133: MERIT Act

ReportedDec 19, 2024

  1. Introduced (completed)Jan 9, 2023
  2. Passed House (not reached)
  3. Passed Senate (not reached)
  4. To the President (not reached)
  5. Became law (not reached)

Summary

Introduced in House, Jan 9, 2023

This bill specifies that coverage determinations for drugs and biologics under Medicare must be made with respect to each drug or biologic, rather than with respect to a class of drugs or biologics.

Written by the Congressional Research Service, Library of Congress.

Roll calls

0 votes on this bill

No roll call votes have been held on this bill.

Amendments

0 offered

No amendments were offered to this bill.

Cosponsors

6

Bipartisan support.

Who scored on this bill

50 points earned
  1. 1Vern Buchanan R-FL SponsorDrew cross-party cosponsors, introduced, reported, discharged4 events+50
See all scorers and every scoring event

Introductions and cosponsorships count toward weekly caps and show no points.

Other bills by Vern Buchanan

History

  1. Jan 9, 2023Introduced in the House by Vern Buchanan.
Show the full action history (13 actions)
  1. Dec 19, 2024Committee on Ways and Means discharged.
  2. Dec 19, 2024Placed on the Union Calendar, Calendar No. 779.
  3. Dec 17, 2024Referred to the Subcommittee on Health.
  4. Nov 22, 2024Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-764, Part I.
  5. Nov 22, 2024House Committee on Ways and Means Granted an extension for further consideration ending not later than Dec. 19, 2024.
  6. Dec 6, 2023Committee Consideration and Mark-up Session Held
  7. Dec 6, 2023Ordered to be Reported (Amended) by the Yeas and Nays: 42 - 0.
  8. Dec 5, 2023Committee Consideration and Mark-up Session Held
  9. Nov 15, 2023Subcommittee Consideration and Mark-up Session Held
  10. Nov 15, 2023Forwarded by Subcommittee to Full Committee in the Nature of a Substitute (Amended) by Voice Vote.
  11. Jan 20, 2023Referred to the Subcommittee on Health.
  12. Jan 9, 2023Introduced in House
  13. Jan 9, 2023Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.